FDA Drug Application (020692) for SEREVENT by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number020692
Product Number001
FormPOWDER;INHALATION
DosageEQ 0.05MG BASE/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSEREVENT
Active IngredientSALMETEROL XINAFOATE

Active IngredientCount
List of drugs with Active Ingredient SALMETEROL XINAFOATE5


Back to FDA Applications sponsored by GLAXOSMITHKLINE